ロード中...

Adjuvant Endocrine Therapy in Premenopausal Patients

Endocrine adjuvant therapy is the best-described molecular targeted treatment and should therefore be used for all patients with endocrine-responsive breast cancer. Ta-moxifen for 5 years is standard of care and has proven efficacy in premenopausal patients. The combination of tamoxifen with ovarian...

詳細記述

保存先:
書誌詳細
第一著者: Gnant, Michael
フォーマット: Artigo
言語:Inglês
出版事項: S. Karger GmbH 2008
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2931102/
https://ncbi.nlm.nih.gov/pubmed/20824025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000156985
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!